Sutro Biopharma Stock Price History
| STRO Stock | USD 0.83 0.07 8.62% |
Below is the normalized historical share price chart for Sutro Biopharma extending back to September 27, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sutro Biopharma stands at 0.83, as last reported on the 21st of July, with the highest price reaching 0.83 and the lowest price hitting 0.76 during the day.
If you're considering investing in Sutro Stock, it is important to understand the factors that can impact its price. Sutro Biopharma appears to be out of control, given 3 months investment horizon. Sutro Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0535, which indicates the firm had a 0.0535 % return per unit of risk over the last 3 months. By inspecting Sutro Biopharma's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please review Sutro Biopharma's Semi Deviation of 6.81, coefficient of variation of 1222.96, and Risk Adjusted Performance of 0.0854 to confirm if our risk estimates are consistent with your expectations. As of the 21st of July 2025, Stock Based Compensation To Revenue is likely to grow to 0.42, while Total Stockholder Equity is likely to drop about 42.4 M. . At this time, Sutro Biopharma's Price To Sales Ratio is very stable compared to the past year. As of the 21st of July 2025, Price Book Value Ratio is likely to grow to 3.33, though Price Earnings Ratio is likely to grow to (0.59). Sutro Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of September 2018 | 200 Day MA 1.7696 | 50 Day MA 0.829 | Beta 1.714 |
Sharpe Ratio = 0.0535
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | STRO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.6 actual daily | 86 86% of assets are less volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Sutro Biopharma is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sutro Biopharma by adding it to a well-diversified portfolio.
Price Book 2.1114 | Enterprise Value Ebitda 0.4055 | Price Sales 0.9662 | Shares Float 65.8 M | Wall Street Target Price 3.2571 |
Sutro Biopharma Stock Price History Chart
There are several ways to analyze Sutro Stock price data. The simplest method is using a basic Sutro candlestick price chart, which shows Sutro Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | April 24, 2025 | 1.3 |
| Lowest Price | July 1, 2025 | 0.68 |
Sutro Biopharma July 21, 2025 Stock Price Synopsis
Various analyses of Sutro Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sutro Stock. It can be used to describe the percentage change in the price of Sutro Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sutro Stock.| Sutro Biopharma Price Rate Of Daily Change | 1.09 | |
| Sutro Biopharma Price Action Indicator | 0.06 | |
| Sutro Biopharma Price Daily Balance Of Power | 0.94 |
Sutro Biopharma July 21, 2025 Stock Price Analysis
Sutro Stock Price History Data
The price series of Sutro Biopharma for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 0.78 with a coefficient of variation of 15.64. The price distribution for the period has arithmetic mean of 0.83. The median price for the last 90 days is 0.83.| Open | High | Low | Close | Volume | ||
07/21/2025 | 0.76 | 0.83 | 0.76 | 0.83 | ||
07/21/2025 | 0.76 | 0.83 | 0.76 | 0.83 | ||
07/18/2025 | 0.77 | 0.80 | 0.76 | 0.76 | 205,763 | |
07/17/2025 | 0.78 | 0.83 | 0.77 | 0.77 | 500,413 | |
07/16/2025 | 0.75 | 0.77 | 0.75 | 0.76 | 282,280 | |
07/15/2025 | 0.75 | 0.79 | 0.74 | 0.75 | 446,154 | |
07/14/2025 | 0.76 | 0.80 | 0.75 | 0.76 | 374,847 | |
07/11/2025 | 0.81 | 0.83 | 0.76 | 0.76 | 229,298 | |
07/10/2025 | 0.78 | 0.83 | 0.78 | 0.82 | 280,861 | |
07/09/2025 | 0.78 | 0.83 | 0.78 | 0.79 | 227,899 | |
07/08/2025 | 0.75 | 0.79 | 0.74 | 0.78 | 370,710 | |
07/07/2025 | 0.76 | 0.77 | 0.73 | 0.74 | 717,534 | |
07/03/2025 | 0.76 | 0.78 | 0.75 | 0.76 | 141,879 | |
07/02/2025 | 0.69 | 0.79 | 0.69 | 0.76 | 970,278 | |
07/01/2025 | 0.72 | 0.73 | 0.67 | 0.68 | 1,100,666 | |
06/30/2025 | 0.74 | 0.77 | 0.71 | 0.71 | 752,239 | |
06/27/2025 | 0.80 | 0.81 | 0.73 | 0.73 | 11,763,555 | |
06/26/2025 | 0.80 | 0.84 | 0.77 | 0.80 | 1,130,065 | |
06/25/2025 | 0.81 | 0.87 | 0.79 | 0.81 | 811,151 | |
| 06/24/2025 | 0.80 | 0.84 | 0.80 | 0.82 | 383,338 | |
06/23/2025 | 0.80 | 0.84 | 0.76 | 0.80 | 657,355 | |
06/20/2025 | 0.82 | 0.84 | 0.80 | 0.80 | 629,391 | |
06/18/2025 | 0.80 | 0.84 | 0.76 | 0.79 | 719,436 | |
06/17/2025 | 0.88 | 0.90 | 0.78 | 0.79 | 887,417 | |
| 06/16/2025 | 0.87 | 0.94 | 0.80 | 0.88 | 1,113,416 | |
06/13/2025 | 0.82 | 0.82 | 0.76 | 0.80 | 700,324 | |
06/12/2025 | 0.84 | 0.84 | 0.78 | 0.81 | 870,396 | |
06/11/2025 | 0.82 | 0.85 | 0.80 | 0.83 | 1,168,790 | |
06/10/2025 | 0.84 | 0.88 | 0.82 | 0.84 | 1,437,994 | |
06/09/2025 | 0.85 | 0.86 | 0.80 | 0.83 | 838,460 | |
| 06/06/2025 | 0.83 | 0.88 | 0.82 | 0.85 | 632,005 | |
06/05/2025 | 0.92 | 0.93 | 0.82 | 0.82 | 1,418,513 | |
06/04/2025 | 0.90 | 0.95 | 0.89 | 0.91 | 515,948 | |
06/03/2025 | 0.90 | 0.95 | 0.87 | 0.91 | 764,843 | |
| 06/02/2025 | 0.88 | 0.92 | 0.87 | 0.90 | 609,291 | |
05/30/2025 | 0.89 | 0.91 | 0.86 | 0.90 | 528,290 | |
05/29/2025 | 0.90 | 0.92 | 0.88 | 0.90 | 616,771 | |
| 05/28/2025 | 0.93 | 0.96 | 0.90 | 0.92 | 667,827 | |
05/27/2025 | 0.88 | 0.96 | 0.88 | 0.94 | 1,044,375 | |
05/23/2025 | 0.87 | 0.92 | 0.85 | 0.92 | 721,587 | |
05/22/2025 | 0.83 | 0.92 | 0.83 | 0.90 | 787,469 | |
05/21/2025 | 0.87 | 0.90 | 0.83 | 0.84 | 711,317 | |
05/20/2025 | 0.87 | 0.90 | 0.82 | 0.90 | 675,841 | |
| 05/19/2025 | 0.91 | 0.99 | 0.85 | 0.88 | 783,141 | |
05/16/2025 | 0.88 | 0.94 | 0.85 | 0.91 | 1,195,144 | |
| 05/15/2025 | 0.74 | 0.89 | 0.72 | 0.88 | 1,749,131 | |
05/14/2025 | 0.82 | 0.83 | 0.72 | 0.73 | 1,359,784 | |
| 05/13/2025 | 0.85 | 0.91 | 0.81 | 0.82 | 1,160,595 | |
05/12/2025 | 0.89 | 1.00 | 0.86 | 0.87 | 1,669,463 | |
| 05/09/2025 | 1.00 | 1.00 | 0.87 | 0.87 | 1,050,359 | |
| 05/08/2025 | 1.00 | 1.00 | 0.89 | 0.96 | 2,219,471 | |
05/07/2025 | 0.94 | 1.00 | 0.93 | 0.99 | 2,361,648 | |
05/06/2025 | 1.03 | 1.03 | 0.94 | 0.95 | 1,833,711 | |
| 05/05/2025 | 1.06 | 1.08 | 0.99 | 1.05 | 1,106,373 | |
05/02/2025 | 1.04 | 1.11 | 1.03 | 1.10 | 1,240,759 | |
05/01/2025 | 1.02 | 1.07 | 0.92 | 1.07 | 1,622,419 | |
04/30/2025 | 0.86 | 1.08 | 0.83 | 1.05 | 2,930,500 | |
04/29/2025 | 0.87 | 0.95 | 0.80 | 0.87 | 3,569,244 | |
04/28/2025 | 0.91 | 0.95 | 0.85 | 0.90 | 1,714,126 | |
04/25/2025 | 1.24 | 1.24 | 0.83 | 0.90 | 5,678,083 | |
04/24/2025 | 0.88 | 1.31 | 0.80 | 1.30 | 4,652,079 |
About Sutro Biopharma Stock history
Sutro Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sutro is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sutro Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sutro Biopharma stock prices may prove useful in developing a viable investing in Sutro Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 76.8 M | 39.1 M | |
| Net Loss | -107.3 M | -101.9 M |
Sutro Biopharma Quarterly Net Working Capital |
|
Sutro Biopharma Stock Technical Analysis
Sutro Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Sutro Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sutro Biopharma's price direction in advance. Along with the technical and fundamental analysis of Sutro Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sutro to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0854 | |||
| Jensen Alpha | 0.2661 | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | 0.0861 | |||
| Treynor Ratio | 0.1939 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Revenue Per Share | Quarterly Revenue Growth 0.338 | Return On Assets | Return On Equity |
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.